Lymphatic filariasis (LF) is a significant public health issue in India. Despite 10–15 rounds of mass drug administration (MDA) in India, the global LF elimination target of 2030 appears challenging. To strengthen the program, community and provider perspectives on ways to bridge a gap in MDA are needed. Through the motivation–opportunity–ability–behaviour (MOAB) lens, we systematically reviewed the facilitators and barriers encountered in LF elimination in India. We followed Preferred Reporting Items for Systematic Review and Meta-Analysis guidelines. We searched PubMed, Embase, ProQuest and Google Scholar databases to explore factors related to MDA program implementation in India through 30 June 2021. We analysed the data using a thematic framework. We identified 576 studies; of these, 20 studies were included. This review revealed that the public health system for distributing MDA drugs in India created a better enabling environment, including zero out-of-pocket expenditure, door-step distribution of medicines and ample capacity-building training and follow-up. However, community members were unaware of the rationale for drug consumption, leading to a gap in drug distribution and consumption. Motivation is required among community members, which suggests capacity-building training for service providers to counsel the community.

中文翻译：

---

印度社区成员和项目实施者大规模用药消除淋巴丝虫病的动机-机会-能力-行为：系统审查和实施优先事项

淋巴丝虫病（LF）是印度的一个重大公共卫生问题。尽管印度进行了 10-15 轮大规模药物管理 (MDA)，但 2030 年全球消除 LF 的目标似乎仍具有挑战性。为了加强该计划，需要社区和提供者就如何弥合 MDA 差距提出看法。通过动机-机会-能力-行为 (MOAB) 的视角，我们系统地回顾了印度消除 LF 过程中遇到的促进因素和障碍。我们遵循系统审查和荟萃分析指南的首选报告项目。我们搜索了 PubMed、Embase、ProQuest 和 Google Scholar 数据库，以探讨截至 2021 年 6 月 30 日与印度 MDA 计划实施相关的因素。我们使用主题框架分析了数据。我们确定了 576 项研究；其中包括 20 项研究。此次审查显示，印度为分发 MDA 药物的公共卫生系统创造了更好的有利环境，包括零自付费用、上门分发药物以及充足的能力建设培训和后续行动。然而，社区成员不了解毒品消费的原因，导致毒品分配和消费存在差距。社区成员需要积极性，这建议对服务提供者进行能力建设培训，为社区提供咨询。